Variant report
Variant | esv3410192 |
---|---|
Chromosome Location | chr6:117396834-117398882 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:117398297..117400947-chr6:117402400..117403953,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372309798 | chr6:117396851-117396852 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201277095 | chr6:117396857-117396858 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556146355 | chr6:117396881-117396882 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577920072 | chr6:117396914-117396915 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545190630 | chr6:117396933-117396934 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140334992 | chr6:117396948-117396949 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145737913 | chr6:117396955-117396956 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542856843 | chr6:117396980-117396981 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561056914 | chr6:117397009-117397010 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115776084 | chr6:117397039-117397040 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543696324 | chr6:117397052-117397053 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs488839 | chr6:117397071-117397072 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs625602 | chr6:117397170-117397171 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs148107748 | chr6:117397257-117397258 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140954857 | chr6:117397258-117397259 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529749177 | chr6:117397292-117397293 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553776089 | chr6:117397425-117397426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190861308 | chr6:117397467-117397468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567479651 | chr6:117397484-117397485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572073534 | chr6:117397501-117397502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538150609 | chr6:117397520-117397521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182771156 | chr6:117397526-117397527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374634694 | chr6:117397559-117397560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199758174 | chr6:117397576-117397577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186511376 | chr6:117397580-117397581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367924768 | chr6:117397581-117397582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147560754 | chr6:117397599-117397600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201273923 | chr6:117397616-117397617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201962321 | chr6:117397621-117397622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71012349 | chr6:117397623-117397624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77231132 | chr6:117397646-117397647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74219790 | chr6:117397649-117397650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13206686 | chr6:117397666-117397667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371735003 | chr6:117397669-117397670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543632285 | chr6:117397688-117397689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71012350 | chr6:117397690-117397691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143495493 | chr6:117397727-117397728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571564715 | chr6:117397751-117397752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141985664 | chr6:117397765-117397766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201122926 | chr6:117397785-117397786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201208671 | chr6:117397823-117397824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113175680 | chr6:117397824-117397825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527336773 | chr6:117397825-117397826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539055022 | chr6:117397890-117397891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553879520 | chr6:117397901-117397902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183584698 | chr6:117398154-117398155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187425895 | chr6:117398277-117398278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554808970 | chr6:117398286-117398287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559378128 | chr6:117398292-117398293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576278003 | chr6:117398330-117398331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:117395800-117397000 | Enhancers | Fetal Heart | heart |
2 | chr6:117396000-117399000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr6:117396400-117397000 | Enhancers | Fetal Lung | lung |
4 | chr6:117396400-117397200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr6:117396400-117398400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr6:117396800-117397400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:117397200-117397400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
8 | chr6:117397400-117399400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:117397400-117399400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |